Stent
Xen gel stent with phaco has similar endothelial cell density loss as cataract surgery alone
Patients who underwent Xen gel stent implantation combined with phacoemulsification to treat primary or secondary open-angle glaucoma experienced a similar central endothelial cell density loss at 2 years as those who underwent stand-alone phacoemulsification, according to a study.
In PCI with dual-therapy stent, no sex differences at 1 year
At 1 year, women experienced similar target lesion failure and ischemic outcomes compared with men after PCI with a dual-therapy stent, according to research published in Catheterization and Cardiovascular Interventions.
VERNACULAR: Venous stent patency remains high at 2 years
Rates of patency and freedom from target lesion revascularization in patients receiving a venous stent were high at 2 years, according to new data from the VERNACULAR trial.
VIRTUS: Venous stent safe, effective at 24 months
Among patients with challenging venous lesions, a venous stent was associated with high rates of primary patency and freedom from major adverse events at 24 months, according to new data from the VIRTUS trial.
Peripheral stent beneficial in common femoral artery stenosis at 2 years
LAS VEGAS — A repuncturable vascular mimetic peripheral stent system was safe and effective at 2 years in patients with common femoral artery disease, according to new data from the VMI-CFA study.
IMPERIAL: Peripheral DES similar in patency, different in TLR at 2 years
LAS VEGAS — A peripheral drug-eluting stent with a polymer coating conferred lower rates of target lesion revascularization compared with a peripheral DES without a polymer coating, according to 2-year results from the IMPERIAL trial.
Mortality not different at 5 years in patients treated with DES vs. controls
LAS VEGAS — There were no significant differences in mortality at 5 years between patients with peripheral artery disease assigned a drug-eluting stent and those assigned a bare-metal stent or percutaneous transluminal angioplasty, according to new data presented at VIVA 19.
Remote robotic-assisted technology could change future of PCI
The concept of robotic-assisted PCI has been successfully implemented since 2011, allowing for precise navigation of catheters and stents while reducing radiation-related risks.
3D-printed patient-specific airway stents may improve patient outcomes
NEW ORLEANS — New data from a small study showed that patient-specific silicone airway stents made using a 3D printer were associated with fewer adverse events than commercially available stents in patients with underlying complex airway disease, researchers reported at the CHEST Annual Meeting.
Another study finds no evidence of increased long-term mortality with paclitaxel-coated devices
Patients who underwent endovascular revascularization with a paclitaxel-based drug-eluting device did not have an increased mortality risk over an 11-year follow-up period, according to a safety analysis published in the European Heart Journal.